GlassScriptPhysician profile
Douglas A Mazurek
NPI 1033223235
$610.69
in general payments reported to CMS, 2019-2025
14 companies · $48.55 in 2025
The $48.55 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12.22 · 2021: $39.02 · 2022: $15.97 · 2024: $495 · 2025: $48.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $543.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $97.04 | 2024 | |
| Inspire Medical Systems, INC. | $76.85 | 2024 | Inspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.41 | 2020-2024 | Ofev |
| Amgen INC. | $66.96 | 2022-2025 | Tezspire |
| Mallinckrodt Hospital Products INC. | $51.76 | 2024 | Acthar |
| Abbvie INC. | $48.22 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $39.74 | 2024 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $35.82 | 2024 | Tezspire |
| Glaxosmithkline, LLC. | $33.69 | 2024 | Arexvy, Trelegy Ellipta |
| Baxter Healthcare | $24.35 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Philips North America LLC | $18.79 | 2024 | (Ak6) Vest Therapy |
| United Therapeutics Corporation | $17.87 | 2021 | |
| Mylan Specialty L.P. | $15.20 | 2024 | Yupelri |
| Electromed, INC. | $14.99 | 2024 | Smartvest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Mazurek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.